Literature DB >> 28671003

Effective antigen delivery via dual entrapment in erythrocytes and autologous plasma beads.

Munazza Tamkeen Fatima1, Ejaj Ahmad1, Mehboob Hoque1.   

Abstract

Fibrin-based polymeric systems have now emerged as efficient carriers of drugs, growth factors, genes, and cells. Earlier, we have reported fibrin-based plasma beads (PB), prepared from clotted whole plasma, as an efficient system for the controlled release of entrapped therapeutics. In the present study, we investigate the dual entrapment in erythrocytes and PB, as potential particulate antigen delivery system in rabbit and mice, with yeast invertase as the model antigen. Preparations used for immunisation include- invertase entrapped in erythrocytes, the same further entrapped in PB, and crosslinked with glutaraldehyde. While route of administration of the antigen only moderately affected the antibody titres, strategies slowing its release from PB increased the antibody titres remarkably, especially after a booster. Entrapment of erythrocytes entrapped antigen in the PB and further crosslinking with glutaraldehyde also resulted in significant alterations of IgG1/IgG2a ratio, indicating a shift towards humoral response. The elicited immune response was more marked in rabbits as compared to that in mice. Considering the well-known toxicity of the adjuvant, comparable antibody titres induced by the erythrocyte-plasma bead system was encouraging in the induction of humoral immunity.

Entities:  

Keywords:  Antigen; adjuvant; drug delivery; erythrocytes; invertase; plasma beads

Mesh:

Substances:

Year:  2017        PMID: 28671003     DOI: 10.1080/1061186X.2017.1350859

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  1 in total

1.  Plasma Bead Entrapped Liposomes as a Potential Drug Delivery System to Combat Fungal Infections.

Authors:  Munazza Tamkeen Fatima; Zeyaul Islam; Ejaj Ahmad; Mehboob Hoque; Marriam Yamin
Journal:  Molecules       Date:  2022-02-07       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.